Real-life data in 115 chronic migraine patients treated with Onabotulinumtoxin A during more than one year
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Real-life data in 115 chronic migraine patients treated with Onabotulinumtoxin A during more than one year
Authors
Keywords
Chronic Migraine, Medication overuse, OnabotulinumtoxinA, Preventatives, Real-life data
Journal
JOURNAL OF HEADACHE AND PAIN
Volume 17, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-12-12
DOI
10.1186/s10194-016-0702-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chronic migraine treatment: from OnabotulinumtoxinA onwards
- (2016) Andrea Negro et al. Expert Review of Neurotherapeutics
- Increased efficacy of regularly repeated cycles with OnabotulinumtoxinA in MOH patients beyond the first year of treatment
- (2016) Simona Guerzoni et al. JOURNAL OF HEADACHE AND PAIN
- Long-term treatment of chronic migraine with OnabotulinumtoxinA: efficacy, quality of life and tolerability in a real-life setting
- (2016) Katja Kollewe et al. JOURNAL OF NEURAL TRANSMISSION
- The use of onabotulinum toxin A (Botox®) in the treatment of chronic migraine at the Parma Headache Centre: a prospective observational study
- (2016) Marco Russo et al. NEUROLOGICAL SCIENCES
- Chronic migraine treatment: from OnabotulinumtoxinA onwards
- (2016) Andrea Negro et al. Expert Review of Neurotherapeutics
- A two years open-label prospective study of OnabotulinumtoxinA 195 U in medication overuse headache: a real-world experience
- (2015) Andrea Negro et al. JOURNAL OF HEADACHE AND PAIN
- Onabotulinum toxin A (Botox) for chronic migraine treatment: an Italian experience
- (2015) L. Grazzi et al. NEUROLOGICAL SCIENCES
- Does analgesic overuse matter? Response to OnabotulinumtoxinA in patients with chronic migraine with or without medication overuse
- (2015) Fayyaz Ahmed et al. SpringerPlus
- OnabotulinumtoxinA treatment for chronic migraine: experience in 52 patients treated with the PREEMPT paradigm
- (2015) María Isabel Pedraza et al. SpringerPlus
- Long-term experience with onabotulinumtoxinA in the treatment of chronic migraine: What happens after one year?
- (2014) Eva Cernuda-Morollón et al. CEPHALALGIA
- Prospective analysis of the use of OnabotulinumtoxinA (BOTOX) in the treatment of chronic migraine; real-life data in 254 patients from Hull, UK
- (2014) Modar Khalil et al. JOURNAL OF HEADACHE AND PAIN
- The International Classification of Headache Disorders, 3rd edition (beta version)
- (2013) CEPHALALGIA
- OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline
- (2013) Stephen D. Silberstein et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Analyses of the 56-Week PREEMPT Clinical Program
- (2011) Sheena K. Aurora et al. HEADACHE
- OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial
- (2010) SK Aurora et al. CEPHALALGIA
- OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial
- (2010) HC Diener et al. CEPHALALGIA
- Global prevalence of chronic migraine: A systematic review
- (2009) JL Natoli et al. CEPHALALGIA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now